Developing new agents for cancer detection and treatment using light
Cationic Carbone-Boracycles as Far-Red and Near-Infrared Photoactive Agents
This study is exploring new light-activated agents that can help doctors see and treat tumors better, aiming to give patients improved ways to find cancer early and receive more effective treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-11037346 on NIH RePORTER |
What this research studies
This research focuses on creating innovative agents that can be activated by light to help diagnose and treat tumors more effectively. By designing and synthesizing special compounds called cationic carbone-boracycles, the project aims to enhance imaging capabilities and improve targeted cancer therapies. These agents are designed to be stable in the body and emit light in the near-infrared range, which can help visualize tumors and deliver localized treatment. Patients may benefit from improved methods for early cancer detection and more effective treatment options.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with cancer who may benefit from advanced imaging and targeted therapies.
Not a fit: Patients with non-cancerous conditions or those who are not undergoing treatment for cancer may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective early detection and treatment options for cancer patients.
How similar studies have performed: Other research has shown promise in using light-activated agents for cancer treatment, indicating that this approach has potential for success.
Where this research is happening
Cambridge, United States
- Massachusetts Institute of Technology — Cambridge, United States (Active)
Researchers
- Principal investigator: Gilliard, Robert J. — Massachusetts Institute of Technology
- Study coordinator: Gilliard, Robert J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.